$14.75
+0.02 (+0.14%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-72.6% upside
Low Target
$2.50
Average Target
$4.04
High Target
$4.74
Current Price
$14.75
Current
$14.75
$14.75
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Scenario Analysis
Bear Case
$2.50
-83.1%
Low target
Base Case
$4.04
-72.6%
Avg target
Bull Case
$4.74
+-67.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$36.79
-59.9% from high
52-Week Low
$5.20
+183.4% from low
Target vs 52W High
$4.04
-89.0% vs high
Next Earnings Report
Nov 18, 2026
4d
until earnings
EPS Est: $-1.28
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |